Distribution and antimicrobial resistance profiles of common blood culture isolates in a maternal and child health specialty hospital, Shenzhen (January 2021–October 2025), China
Open Access
- 6 March 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 17, 1756119
Abstract
Objective: To investigate the distribution and antimicrobial resistance profiles of pathogens causing bloodstream infections (BSIs) in a maternal and child health hospital, providing evidence for rational clinical therapy. Methods: A retrospective analysis was conducted on 395 bacterial isolates recovered from positive blood cultures of inpatients at Longgang District Maternity & Child Healthcare Hospital of Shenzhen City between January 1, 2021 and October 31, 2025. Duplicate isolates from the same patient were excluded. Results: Among all isolates, Gram-positive bacteria accounted for 60.5% and Gram-negative bacteria for 39.5%. Coagulase-negative staphylococci (40.3%) were the most frequently detected, although many were likely contaminants. The major clinically relevant pathogens were Escherichia coli (28.6%), Streptococcus agalactiae (3.3%), Klebsiella pneumoniae subsp. pneumoniae (2.8%), and Staphylococcus aureus (2.3%). Escherichia coli showed a 44.3% Extended-Spectrum β -Lactamase (ESBL)-positive rate and elevated resistance to third-generation cephalosporins, with one carbapenem-resistant Enterobacteriaceae (CRE) isolate identified. Klebsiella pneumoniae exhibited overall low resistance levels. Among Staphylococcus aureus , methicillin-resistant Staphylococcus aureus (MRSA) accounted for 22.2%, all susceptible to vancomycin, linezolid, and tigecycline. Streptococcus agalactiae retained excellent β -lactam and glycopeptide susceptibility, whereas Streptococcus pneumoniae exhibited pronounced macrolide resistance. Conclusion: Escherichia coli and Staphylococcus aureus were the leading pathogens. The high ESBL rate in Escherichia coli and the detection of a CRE isolate indicate emerging β -lactam resistance risks. Although MRSA was detected, complete susceptibility to glycopeptides was preserved, highlighting the importance of ongoing monitoring.Keywords
This publication has 34 references indexed in Scilit:
- Predicting appropriateness of antibiotic treatment among ICU patients with hospital-acquired infectionnpj Digital Medicine, 2025
- Rapid molecular assays versus blood culture for bloodstream infections: a systematic review and meta-analysiseClinicalMedicine, 2025
- Next-generation rapid phenotypic antimicrobial susceptibility testingNature Communications, 2024
- Bloodstream infections: mechanisms of pathogenesis and opportunities for interventionNature Reviews Microbiology, 2024
- Epidemiology and clinical relevance of persistent bacteraemia in patients with Gram-negative bloodstream infection: a retrospective cohort studyJournal of Antimicrobial Chemotherapy, 2024
- Risk factors for bloodstream infection among patients admitted to an intensive care unit of a tertiary hospital of Shanghai, ChinaScientific Reports, 2024
- Carbapenem-resistant Enterobacterales colonization and subsequent infection in a neonatal intensive care unit in Shanghai, ChinaInfection Prevention in Practice, 2021
- Central venous catheter–related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)Annals of Hematology, 2020
- China’s migrant population and healthChina Population and Development Studies, 2019
- Contaminants in blood cultures: importance, implications, interpretation and preventionClinical Microbiology and Infection, 2018